|
|
Article: FDA Announces Initiative to Bolster Generic Drug Program Effort will streamline generic drug approval process; provide more o ptions for consumers, health professionals.
- Article from:
- M2 Presswire
- Article date:
- October 5, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-5 October 2007-US FDA: FDA Announces Initiative to Bolster Generic Drug Program Effort will streamline generic drug approval process; provide more o ptions for consumers, health professionals(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:04102007
The U.S. Food and Drug Administration today outlined a program aimed at increasing the number and variety of generic drug products available to consumers and health care providers.
Generic drugs generally cost less than their brand-name counterparts and competition among generics has been a key factor in lowering drug prices. The Generic Initiative for Value and Efficiency, or GIVE, will help ...